BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38364915)

  • 1. Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.
    Kou L; Chi X; Sun Y; Yin S; Wu J; Zou W; Wang Y; Jin Z; Huang J; Xiong N; Xia Y; Wang T
    Ageing Res Rev; 2024 Mar; 95():102232. PubMed ID: 38364915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronobiology of Parkinson's disease: Past, present and future.
    Asadpoordezaki Z; Coogan AN; Henley BM
    Eur J Neurosci; 2023 Jan; 57(1):178-200. PubMed ID: 36342744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian regulation of astrocyte function: implications for Alzheimer's disease.
    McKee CA; Lananna BV; Musiek ES
    Cell Mol Life Sci; 2020 Mar; 77(6):1049-1058. PubMed ID: 31578625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOX2 inhibition enables retention of the circadian clock in BV2 microglia and primary macrophages.
    Muthukumarasamy I; Buel SM; Hurley JM; Dordick JS
    Front Immunol; 2023; 14():1106515. PubMed ID: 36814920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease.
    Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF
    Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic implications of circadian clocks in neurodegenerative diseases.
    Chang YC; Kim JY
    J Neurosci Res; 2020 Jun; 98(6):1095-1113. PubMed ID: 31833091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythms and glial cells of the central nervous system.
    Brécier A; Li VW; Smith CS; Halievski K; Ghasemlou N
    Biol Rev Camb Philos Soc; 2023 Apr; 98(2):520-539. PubMed ID: 36352529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MUL1 and PARKIN on the circadian clock, brain and behaviour in Drosophila Parkinson's disease models.
    Doktór B; Damulewicz M; Pyza E
    BMC Neurosci; 2019 May; 20(1):24. PubMed ID: 31138137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythms in neurodegenerative disorders.
    Nassan M; Videnovic A
    Nat Rev Neurol; 2022 Jan; 18(1):7-24. PubMed ID: 34759373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming and polarization of microglia in Parkinson's disease: Role of inflammasome and iron.
    Yu H; Chang Q; Sun T; He X; Wen L; An J; Feng J; Zhao Y
    Ageing Res Rev; 2023 Sep; 90():102032. PubMed ID: 37572760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglial circadian clock regulation of microglial structural complexity, dendritic spine density and inflammatory response.
    Nakanishi H; Ni J; Nonaka S; Hayashi Y
    Neurochem Int; 2021 Jan; 142():104905. PubMed ID: 33217515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The wrinkling of time: Aging, inflammation, oxidative stress, and the circadian clock in neurodegeneration.
    Lananna BV; Musiek ES
    Neurobiol Dis; 2020 Jun; 139():104832. PubMed ID: 32179175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
    Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between circadian rhythms and neurodegenerative diseases.
    Leng Y; Musiek ES; Hu K; Cappuccio FP; Yaffe K
    Lancet Neurol; 2019 Mar; 18(3):307-318. PubMed ID: 30784558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders.
    Ribeiro RFN; Pereira D; de Almeida LP; Silva MMC; Cavadas C
    Aging Clin Exp Res; 2022 Dec; 34(12):2963-2976. PubMed ID: 36306110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell clocks and neuronal networks: neuron ticking and synchronization in aging and aging-related neurodegenerative disease.
    Bonaconsa M; Colavito V; Pifferi F; Aujard F; Schenker E; Dix S; Grassi-Zucconi G; Bentivoglio M; Bertini G
    Curr Alzheimer Res; 2013 Jul; 10(6):597-608. PubMed ID: 23627753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the circadian system in Parkinson's disease patients.
    Fifel K
    Mov Disord; 2017 May; 32(5):682-692. PubMed ID: 27859638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Circadian Clock of Polarized Microglia and Its Interaction with Mouse Brain Oscillators.
    Honzlová P; Semenovykh K; Sumová A
    Cell Mol Neurobiol; 2023 Apr; 43(3):1319-1333. PubMed ID: 35821305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.